FDA approves Aleors Diclofenac sodium topical solution
The US Food and Drug Administration (FDA) has granted tentative approval for Aleor Dermaceuticals’ Diclofenac...
Aptar Pharma, Platinum Sponsor at DDL 2019, to Showcase Expanded Portfolio of Respiratory Innovations...
Aptar Pharma, a leading drug delivery systems provider, announces its Platinum Sponsorship of this year’s...
Chi-Med Announces Surufatinib Granted FDA Orphan Drug Designation for Pancreatic Neuroendocrine Tumors
Hutchison China MediTech Limited announces that the U.S. FDA has granted Orphan Drug designation to...
Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases
Bayer and Dewpoint Therapeutics, a biotechnology company with sites in Boston and Dresden, Germany, announced...
DuPont Reveals Enhanced Application and Innovation Center, Increased Production Capacity at CPhI India
DuPont Nutrition & Biosciences has consistently advanced its customers forward by ensuring global access to...
Dicerna, Novo Nordisk sign RNAi deal for liver-related cardio-metabolic diseases
US-based Dicerna Pharmaceuticals and Novo Nordisk have signed a deal worth up to around $607m...
WuXi STA Forms Strategic Partnership with Impact Therapeutics
STA Pharmaceutical Co Ltd – a subsidiary of WuXi AppTec – and Impact Therapeutics, a...
Lonza Partners with Cryoport and Strengthens its Vein-to-vein Delivery Network in Cell & Gene...
Lonza and Cryoport, Inc announced their partnership in the cell and gene therapy field and...
A2 Biotherapeutics emerges from Stealth Mode to develop tumour cell therapeutics
A2 Biotherapeutics, a biotechnology company developing innovative cell therapies for cancer patients, announced its official...
CDMOs to benefit from rising BTDs, orphan drugs and fast track status
CPhI Worldwide – the world’s largest pharma event taking place in Frankfurt (5th – 7th...